Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
N Engl J Med. 2009 Apr 9;360(15):1487-99. doi: 10.1056/NEJMoa0806290.

Efficacy of esomeprazole for treatment of poorly controlled asthma.

Collaborators (180)

Hanania NA, Sockrider M, Giraldo L, Valdez R, Flores E, Reibman J, DiMango E, Rogers L, Cammarata C, Carapetyan K, Sormillon J, Simpson E, Williams L, Sundy J, Dudek G, Newton R, Dugdale A, Teague WG, Fitzpatrick A, Khatri S, Patel R, Peabody J, Hunter E, Whitlock D, Smith L, Moy J, Naureckas E, Olopade CS, Hixon J, Brees A, Rivera G, Sietsema S, Zagaja V, Busk M, Williams C, Puntenney P, Busk N, Leone F, Hayes-Hampton M, Summer WR, Meyaski G, Wenzel S, Katial R, Lopez L, Lima J, Blake K, Santos A, Vega K, Lambiase L, Langford T, Schaeffer D, Lang J, McRae M, Karpel J, Cohen R, Ramdeo R, Irvin CG, Dixon AE, Kaminsky DA, Colletti R, Burns SM, Bourassa LM, Lang SE, Griffes LV, Pratt R, Nakos KB, Girard KJ, Mastronarde J, McCoy K, Parsons J, Drake J, Compton R, Raterman L, Cosmar D, Gerald LB, Bailey WC, Erwin S, Kelley A, Laken D, Wanner A, Lockey R, Mendes E, McCullough S, Fimbel B, Grandstaff M, Blumenthal MN, Brottman G, Hagen J, Decker A, Lascewski D, Kelleher S, Bachman K, Quintard C, Sherry C, Salzman G, Pyszczynski D, Haney P, Castro M, Bacharier L, Sumino K, Scheipeter ME, Tarsi J, Wasserman S, Ramsdell J, Vitin J, Tucker T, Anthonisen N, Wise R, Holbrook J, Brown E, Amend-Libercci D, Barry K, Daniel M, Lears A, Leatherman G, Levine C, Masih R, Modak S, Nowakowski D, Prusakowski N, Shade D, Shiflett C, Sugar E, Richter J, Anthonisen N, Lancet E, Santos A, Taggart V, Edelman N, Wise R, Holbrook J, Hanania N, Williams L, Teague G, Smith L, Busk M, Leone F, Karpel J, Summer W, Blumenthal M, Lima J, Katial R, Irvin C, Reibman J, Dozor A, Mastronarde J, Castro M, Gerald L, Salzman G, Wanner A, Wasserman S, Lazarus S, Calhoun W, Kahrilas P, McWilliams B, Rogatko A, Sorkness C, Lancet E, Vento R, Edelman N, Rappaport S, Pezza G, Taggart V, Weinmann G, Snider G, Anthonisen N, Castro M, Fish J, Ingbar D, Jenkinson S, Mannino D, Perlstadt H, Rosenwasser L, Samet J, Schraufnagel D, Smith J, Smith L, Standiford T, Wanner A, Weaver T.

Abstract

BACKGROUND:

Gastroesophageal reflux is common among patients with asthma but often causes mild or no symptoms. It is not known whether treatment of gastroesophageal reflux with proton-pump inhibitors in patients who have poorly controlled asthma without symptoms of gastroesophageal reflux can substantially improve asthma control.

METHODS:

In a parallel-group, double-blind trial, we randomly assigned 412 participants with inadequately controlled asthma, despite treatment with inhaled corticosteroids, and with minimal or no symptoms of gastroesophageal reflux to receive either 40 mg of esomeprazole twice a day or matching placebo. Participants were followed for 24 weeks with the use of daily asthma diaries, spirometry performed once every 4 weeks, and questionnaires that asked about asthma symptoms. We used ambulatory pH monitoring to ascertain the presence or absence of gastroesophageal reflux in the participants. The primary outcome was the rate of episodes of poor asthma control, as assessed on the basis of entries in asthma diaries.

RESULTS:

Episodes of poor asthma control occurred with similar frequency in the placebo and esomeprazole groups (2.3 and 2.5 events per person-year, respectively; P=0.66). There was no treatment effect with respect to individual components of the episodes of poor asthma control or with respect to secondary outcomes, including pulmonary function, airway reactivity, asthma control, symptom scores, nocturnal awakening, or quality of life. The presence of gastroesophageal reflux, which was documented by pH monitoring in 40% of participants with minimal or no symptoms, did not identify a subgroup of patients that benefited from treatment with proton-pump inhibitors. There were fewer serious adverse events among patients receiving esomeprazole than among those receiving placebo (11 vs. 17).

CONCLUSIONS:

Despite a high prevalence of asymptomatic gastroesophageal reflux among patients with poorly controlled asthma, treatment with proton-pump inhibitors does not improve asthma control. Asymptomatic gastroesophageal reflux is not a likely cause of poorly controlled asthma. (ClinicalTrials.gov number, NCT00069823.)

2009 Massachusetts Medical Society

Comment in

PMID:
19357404
[PubMed - indexed for MEDLINE]
PMCID:
PMC2974569
Free PMC Article

Images from this publication.See all images (1)Free text

Figure 1
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Atypon Icon for PubMed Central
    Loading ...
    Write to the Help Desk